跳至主要内容
临床试验/NL-OMON55503
NL-OMON55503招募中不适用

Tau PET imaging in cognitively normal elderly subjects: A twin approach - Tau Twin

Vrije Universiteit Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion in PreclinAD study (2014.210) and a subject must be older than 60
  • years, have received an [18F]flutemetamol amyloid PET scan and/or have a known
  • amyloid status obtained from CSF.

排除标准

  • 1.Has contra indications for MRI scanning and therefore has not received brain
  • 2.Has evidence of structural abnormalities such as major stroke or mass on MRI
  • that is likely to interfere with interpretation of PET scan;
  • 3.Has a relevant history of severe drug allergy or hypersensitivity. Relevant
  • severe drug allergies should be determined by the Principal Investigator or
  • Co-Principal Investigator, and any questions about a subject*s eligibility can
  • be directed to Avid Radiopharmaceuticals Inc.;
  • 4.Has ever participated in an experimental study with a tau agent, unless it
  • can be documented that the subject received only placebo during the course of
  • 5.Has been injected with a previously administered radiopharmaceutical within 6
  • terminal half-lives or when total yearly radiation exposure exceeds 16.1 mSv
  • for female and 22.4 mSv for male participants.
  • 6.Has a history of severe traumatic brain

研究者

相似试验